UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature cell biology, ISSN 1465-7392, 08/2018, Volume 20, Issue 8, pp. 954 - 965
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Osteosarcoma - drug therapy | Mad2 Proteins - metabolism | Humans | Multiprotein Complexes | Ovarian Neoplasms - pathology | Bone Neoplasms - pathology | DNA Breaks, Double-Stranded | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Ovarian Neoplasms - genetics | Telomere-Binding Proteins - genetics | DNA End-Joining Repair | HEK293 Cells | Female | Bone Neoplasms - genetics | Ovarian Neoplasms - metabolism | Bone Neoplasms - drug therapy | BRCA1 Protein - deficiency | Telomere-Binding Proteins - metabolism | Ovarian Neoplasms - drug therapy | Osteosarcoma - metabolism | DNA-Binding Proteins | Tumor Suppressor p53-Binding Protein 1 - metabolism | Recombinational DNA Repair | Tumor Suppressor p53-Binding Protein 1 - genetics | Cisplatin - pharmacology | Breast Neoplasms - drug therapy | Proteins - genetics | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Proteins - metabolism | Breast Neoplasms - pathology | Mad2 Proteins - genetics | Cell Line, Tumor | Mice | Osteosarcoma - genetics | Cell Cycle Proteins | Osteosarcoma - pathology | Care and treatment | DNA | Cancer cells | Breast cancer | Genetic aspects | Research | Gene expression | Single-stranded DNA | DNA damage | Homologous recombination | Poly(ADP-ribose) | Homology | Genomes | Inactivation | Proteins | Ribose | Null cells | Deoxyribonucleic acid--DNA | BRCA2 protein | CRISPR | Deactivation | BRCA1 protein | Poly(ADP-ribose) polymerase | Adenosine diphosphate | Oligosaccharides | Double-strand break repair | Screens | Cisplatin | Inhibitors | Prostate | Viability | Tumors | Index Medicus | Telomere-Binding Proteins / metabolism | Osteosarcoma / genetics | Telomere-Binding Proteins / genetics | BRCA1 Protein / genetics | Cellular Biology | Genetics | Proteins / genetics | Osteosarcoma / drug therapy | Ovarian Neoplasms / genetics | Mad2 Proteins / genetics | Proteins / metabolism | Breast Neoplasms / drug therapy | Breast Neoplasms / metabolism | Tumor Suppressor p53-Binding Protein 1 / genetics | BRCA1 Protein / deficiency | Ovarian Neoplasms / metabolism | Mad2 Proteins / metabolism | Breast Neoplasms / pathology | Bone Neoplasms / genetics | Ovarian Neoplasms / pathology | Bone Neoplasms / pathology | Life Sciences | Bone Neoplasms / drug therapy | Ovarian Neoplasms / drug therapy | Osteosarcoma / metabolism | Biochemistry, Molecular Biology | Breast Neoplasms / genetics | Drug Resistance, Neoplasm / genetics | Osteosarcoma / pathology | Bone Neoplasms / metabolism | Poly(ADP-ribose) Polymerase Inhibitors / pharmacology | Cisplatin / pharmacology | Molecular biology | Tumor Suppressor p53-Binding Protein 1 / metabolism | Cancer
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 75 - 87
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Germ-Line Mutation - genetics | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - genetics | Female | Antineoplastic Agents - pharmacology | Poly(ADP-ribose) Polymerases - chemistry | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - pathology | Survival Rate | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | BRCA1 Protein - genetics | International Agencies | Peritoneal Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Indoles - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | BRCA2 Protein - genetics | Drug Resistance, Neoplasm - drug effects | Sugars | Monosaccharides | Ovarian cancer | Analysis | Carcinoma | Cancer | Index Medicus
Journal Article
Journal of proteomics, ISSN 1874-3919, 2010, Volume 73, Issue 10, pp. 1921 - 1944
Imaging mass spectrometry | MSI | Biomarker | Histopathology | MALDI | Cancer | Lung Neoplasms/chemistry | Humans | Male | Pancreatic Neoplasms/chemistry | Specimen Handling | Ovarian Neoplasms/chemistry | Brain Neoplasms/chemistry | Prostatic Neoplasms/chemistry | Biopsy | Biomarkers, Tumor/analysis | Proteomics/methods | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods | Brain Chemistry | Breast Neoplasms/chemistry | Neoplasm Proteins/analysis | Gastrointestinal Neoplasms/chemistry | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Biochemical Research Methods | Science & Technology | Brain Neoplasms - chemistry | Ovarian Neoplasms - chemistry | Pancreatic Neoplasms - chemistry | Prostatic Neoplasms - chemistry | Lung Neoplasms - chemistry | Biomarkers, Tumor - analysis | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Breast Neoplasms - chemistry | Gastrointestinal Neoplasms - chemistry | Neoplasm Proteins - analysis | Proteomics - methods
Journal Article
Modern pathology, ISSN 0893-3952, 08/2015, Volume 28, Issue 8, pp. 1101 - 1122
Life Sciences & Biomedicine | Pathology | Science & Technology | Predictive Value of Tests | Humans | Ovarian Neoplasms - pathology | Immunohistochemistry - standards | Carcinoma - chemistry | Peritoneal Neoplasms - chemistry | Ovarian Neoplasms - genetics | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Fallopian Tube Neoplasms - chemistry | Fallopian Tube Neoplasms - genetics | Female | Molecular Diagnostic Techniques - standards | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Carcinoma - pathology | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Pathology, Clinical - standards | Diagnosis, Differential | Ovarian Neoplasms - chemistry | Biopsy - standards | Biomarkers, Tumor - analysis | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Fallopian Tube Neoplasms - pathology | Fallopian Tube Neoplasms - surgery | Peritoneal Neoplasms - genetics | Carcinoma - genetics | Research Design - standards | Biomarkers, Tumor - genetics | Neoplasm Staging | Ovarian Neoplasms - surgery | Index Medicus
Journal Article
Modern pathology, ISSN 0893-3952, 12/2011, Volume 24, Issue 12, pp. 1560 - 1570
angiomatoid fibrous histiocytoma | ovarian neoplasm | vulval neoplasm | mediastinal neoplasm | retroperitoneal neoplasm | soft tissue tumor | Life Sciences & Biomedicine | Pathology | Science & Technology | Immunohistochemistry | Translocation, Genetic | Mediastinal Neoplasms - genetics | Histiocytoma, Malignant Fibrous - chemistry | Humans | Middle Aged | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Retroperitoneal Neoplasms - chemistry | Ovarian Neoplasms - genetics | Young Adult | Vulvar Neoplasms - pathology | Retroperitoneal Neoplasms - genetics | Adult | Female | Retroperitoneal Neoplasms - pathology | Histiocytoma, Malignant Fibrous - pathology | Lung Neoplasms - genetics | Ovarian Neoplasms - chemistry | Lung Neoplasms - chemistry | Biomarkers, Tumor - analysis | Gene Fusion | In Situ Hybridization, Fluorescence | Reverse Transcriptase Polymerase Chain Reaction | Histiocytoma, Malignant Fibrous - genetics | Mediastinal Neoplasms - chemistry | Vulvar Neoplasms - genetics | Mediastinal Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Vulvar Neoplasms - chemistry | Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 09/2007, Volume 31, Issue 9, pp. 1356 - 1362
Retroperitoneum | Sarcomatous components | Mediastinum | Gonads | Germ cell tumors | Cisplatinum chemotherapy | Biological and medical sciences | Investigative techniques, diagnostic techniques (general aspects) | Medical sciences | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Immunohistochemistry | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Retroperitoneal Neoplasms - therapy | Male | Sarcoma - therapy | Neoplasms, Germ Cell and Embryonal - diagnosis | Retroperitoneal Neoplasms - diagnosis | Testicular Neoplasms - pathology | Neoplasms, Germ Cell and Embryonal - chemistry | Retroperitoneal Neoplasms - chemistry | Neoplasm Metastasis | Time Factors | Mediastinal Neoplasms - therapy | Adult | Female | Sarcoma - diagnosis | Retroperitoneal Neoplasms - pathology | Testicular Neoplasms - diagnosis | Testicular Neoplasms - therapy | Ovarian Neoplasms - chemistry | Ovariectomy | Ovarian Neoplasms - diagnosis | Antineoplastic Combined Chemotherapy Protocols | Treatment Outcome | Mediastinal Neoplasms - diagnosis | Sarcoma - pathology | Orchiectomy | Disease-Free Survival | Sarcoma - chemistry | Mediastinal Neoplasms - chemistry | Mediastinal Neoplasms - pathology | Adolescent | Ovarian Neoplasms - therapy | Aged | Testicular Neoplasms - chemistry | Neoplasm Staging | Neoplasms, Germ Cell and Embryonal - pathology | Neoplasms, Germ Cell and Embryonal - therapy | Index Medicus
Journal Article
7.
Full Text
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Nature (London), ISSN 0028-0836, 2013, Volume 497, Issue 7447, pp. 108 - 112
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lung Neoplasms - drug therapy | Genomics | Humans | ErbB Receptors - genetics | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Ovarian Neoplasms - genetics | Neoplasms - genetics | DNA Mutational Analysis | Female | Antineoplastic Agents - pharmacology | DNA, Neoplasm - analysis | Ovarian Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Intercellular Signaling Peptides and Proteins - genetics | Breast Neoplasms - drug therapy | Genome, Human - genetics | Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Drug Resistance, Neoplasm - genetics | Exome - genetics | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Breast Neoplasms - pathology | Retinoblastoma Protein - genetics | Plasma - chemistry | Alleles | Carcinoma, Non-Small-Cell Lung - drug therapy | DNA, Neoplasm - genetics | Neoplasms - pathology | Mediator Complex Subunit 1 - genetics | Drug Resistance, Neoplasm - drug effects | Evolution, Molecular | Antimitotic agents | Care and treatment | Physiological aspects | Dosage and administration | Genetic aspects | Research | Nucleotide sequencing | Drug resistance | Antineoplastic agents | DNA sequencing | Blood plasma | Cancer | Plasma | Biopsy | Breast cancer | Genomes | Mutation | Patients | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Advances in anatomic pathology, ISSN 1072-4109, 01/2006, Volume 13, Issue 1, pp. 8 - 15
Immunohistochemistry | Diagnosis | Gynecologic neoplasms | p16 | Life Sciences & Biomedicine | Pathology | Science & Technology | Carcinoma, Small Cell - genetics | Humans | Cystadenocarcinoma, Serous - genetics | Genital Neoplasms, Female - diagnosis | Ovarian Neoplasms - genetics | Carcinoma, Small Cell - chemistry | Cystadenocarcinoma, Serous - chemistry | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Endometrial Neoplasms - genetics | Tumor Suppressor Proteins - genetics | Female | Vulvar Neoplasms - diagnosis | Adenocarcinoma - genetics | Uterine Neoplasms - diagnosis | Adenocarcinoma - chemistry | Genital Neoplasms, Female - genetics | Genitalia, Female - chemistry | Uterine Neoplasms - chemistry | Uterine Neoplasms - genetics | Vulvar Neoplasms - classification | Diagnosis, Differential | Ovarian Neoplasms - chemistry | Uterine Cervical Neoplasms - diagnosis | Endometrial Neoplasms - chemistry | Biomarkers, Tumor - analysis | Ovarian Neoplasms - diagnosis | Genital Neoplasms, Female - chemistry | Endometrial Neoplasms - diagnosis | Uterine Cervical Neoplasms - genetics | Genes, p16 | Carcinoma, Small Cell - diagnosis | Genitalia, Female - physiopathology | Adenocarcinoma - diagnosis | Vulvar Neoplasms - genetics | Biomarkers, Tumor - genetics | Uterine Cervical Neoplasms - chemistry | Cystadenocarcinoma, Serous - diagnosis | Tumor Suppressor Proteins - analysis | Vulvar Neoplasms - chemistry | Index Medicus
Journal Article